Status:
UNKNOWN
The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset
Lead Sponsor:
Peking University
Conditions:
Treatment-resistant Schizophrenia
Eligibility:
All Genders
18-45 years
Brief Summary
Previous long-term follow-up studies on patients with first-episode schizophrenia have shown that up to 30% of patients who have never received antipsychotic medication treatment do not experience sym...
Detailed Description
Research steps: (1) First, based on the applicant's project funded by the National Natural Science Foundation of China (National Natural Science Foundation: Precise Identification and Treatment of Tre...
Eligibility Criteria
Inclusion
- Having a diagnosis of schizophrenics based on the patient edition of the Structured Clinical Interview for Axis I Diagnostic and Statistical Manual-IV Axis I Disorders (SCID).
- Age 18-45 years.
- First episode of schizophrenia.
- Course of disease ≤ 3 years.
- Previous continuous medication ≤ 4 weeks, cumulative intermittent medication ≤ 12 weeks.
- Be able to understand the interview content and sign written informed consent.
Exclusion
- Previous history of major physical diseases.
- Previous substance abuse or dependence.
- Contraindications to olanzapine, risperidone or aripiprazole.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 13 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06128408
Start Date
December 1 2023
End Date
October 13 2024
Last Update
November 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.